As has been the case with the EGFR protein and its therapeutic antibodies targeting different epitopes29, it may thus be possible to develop antibody therapies that are specifically directed against cancer cell expressed versus immune suppressor cell expressed forms of RON extending the value of RON as a target in the immunotherapy of cancer and permitting image guided personalised medicine. The gene discussed is EGFR; the disease is cancer.